Compared with that observed with KLC4 siRNA treatment alone, knockdown of KLC4 in combination with cisplatin also increased lung cancer cell death, as was evident from the evaluation of apoptosis using flow cytometry (Fig. 2b, Supplementary Fig. 1b). Here, KLC4 is linked to lung cancer.